Novamigra Therapeutics secures ~€3 million funding to advance first-in-human Phase 1 study of its migraine prophylaxis ...
Bruce Ogilvie, Executive Chairman of Alliance Entertainment, appears on the RedChip Small Stocks Big Money ™ show on Bloomberg TV to discuss Alliance Entertainment’s position at the center of the ...
Your veterinarian has just finished your dog’s exam, and tells you that your pal needs medication for its problem. You remember how hard it is to get your ...
UCSF is seeking volunteers for a trial using LSD to treat generalized anxiety disorder - a poorly understood and potentially ...
Industry Trends and Global Forecasts, Till 2035" report has been added to ResearchAndMarkets.com's offering. The global GLP-1 market is estimated to grow from USD 62.2 billion in the current year to ...
MEDVi, a telehealth platform serving more than 100,000 patients, today announced continued nationwide momentum as ...
Also, amid the media requests, Capitol Forum continued its industrial-scale FDA surveillance, filing 80 separate FOIA requests in November, largely aimed at harvesting Form 483s, Establishment ...
Everyday Health on MSN
My insurance won’t cover GLP-1 drugs. What now?
Today, the compounded GLP-1 market is in upheaval. The FDA has banned copies of GLP-1 weight loss drugs, and a number of ...
Together, Pentec and Hartley bring an integrated approach to intrathecal therapy, spanning medication preparation, clinical care, and administrative support. The combined model is intended to support ...
In the fight against climate change, companies are navigating compounding problems: supply-chain issues, tariffs, changing ...
A new kind of microscope is giving scientists a way to watch life inside cells with a clarity that feels almost unfair.
Hims & Hers Health, Inc. analysis: subscription health platform growth, GLP-1 risks, and catalysts in women’s health & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results